Correction:  Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Ran Zhang; Xiaoxiao Wang; Mei Hong; Ting Luo; Miaomiao Zhao; Haorui Shen; Jun Fang; Xiaojie Li; Sibin Zang; Ping Chen; Dimin Nie; Peng Zheng; Qiuling Wu; Linghui Xia

doi:10.18632/oncotarget.20579

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

PDF | How to cite

Oncotarget. 2017; 8:60000-60000. https://doi.org/10.18632/oncotarget.20579

Metrics: PDF 2298 views | ?

Ran Zhang^1,*, Xiaoxiao Wang^1,*, Mei Hong^1,*, Ting Luo¹, Miaomiao Zhao¹, Haorui Shen¹, Jun Fang¹, Xiaojie Li¹, Sibin Zang¹, Ping Chen¹, Dimin Nie¹, Peng Zheng¹, Qiuling Wu¹, Linghui Xia¹

¹ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
^* These authors contributed equally to this work

Published: August 29, 2017

This article has been corrected: the institution information was updated to include the postal code. The authors sincerely apologize for this oversight.

Original article: Oncotarget. 2017;8:23360-75. DOI:https://doi.org/10.18632/oncotarget.15579.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20579

Publication Alerts

Post-Publication Promotion

Corrections:

Correction: Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation